trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['great work', 'head and neck']
this is the "destiny" trial for head and neck cancer patients.
this is affordable enough to change their destiny.
great work and team 
Young Oncologists Group India-
(Medical, Surgical ,Radiation, Palliative , Preventive, OncoPathology, Oncoradiology) 
I Global Oncology Initiative ???? I